Ofloxacin Dosing and Duration
For adults, ofloxacin is dosed at 400 mg every 12 hours orally for most infections, with treatment duration varying from 3-14 days depending on the specific infection type. For children, the dose is 7.5 mg/kg every 12 hours orally (maximum 400 mg/dose), though ofloxacin is not FDA-approved for pediatric use and should be reserved for situations where no alternative exists 1.
Adult Dosing by Indication
The FDA-approved dosing varies significantly by infection type 1:
Respiratory Infections
- Acute bacterial exacerbation of chronic bronchitis: 400 mg every 12 hours for 10 days
- Community-acquired pneumonia: 400 mg every 12 hours for 10 days
Skin and Soft Tissue Infections
- Uncomplicated skin infections: 400 mg every 12 hours for 10 days
Genitourinary Infections
- Uncomplicated gonorrhea: 400 mg single dose
- Nongonococcal cervicitis/urethritis (C. trachomatis): 300 mg every 12 hours for 7 days
- Mixed urethral/cervical infection: 300 mg every 12 hours for 7 days
- Acute pelvic inflammatory disease: 400 mg every 12 hours for 10-14 days
- Uncomplicated cystitis (E. coli or K. pneumoniae): 200 mg every 12 hours for 3 days
- Uncomplicated cystitis (other pathogens): 200 mg every 12 hours for 7 days
- Complicated UTIs: 200 mg every 12 hours for 10 days
- Prostatitis (E. coli): 300 mg every 12 hours for 6 weeks
Bioterrorism/Plague Prophylaxis
For plague exposure prophylaxis, adults receive 400 mg every 12 hours orally for 7 days 2.
Pediatric Dosing
Children aged ≥1 month to ≤17 years receive 7.5 mg/kg every 12 hours orally (maximum 400 mg/dose) 2. This applies to:
- Plague prophylaxis: 7 days duration
- Plague treatment (bubonic/pharyngeal): 10-14 days duration
Critical Pediatric Considerations
- Ofloxacin is not FDA-approved for children due to concerns about cartilage and bone growth effects 3, 4
- An oral suspension formulation is not available in the United States 2
- Use should be restricted to situations where organisms are resistant to first-line agents or when no safer alternatives exist
- Long-term use (>several weeks) has not been approved in children and adolescents 3, 4
Renal Dose Adjustments
Dosing must be adjusted when creatinine clearance falls below 50 mL/min 1:
- CrCl 20-50 mL/min: Give the usual recommended unit dose every 24 hours (instead of every 12 hours)
- CrCl <20 mL/min: Give half the usual recommended unit dose every 24 hours
For example, if the standard dose is 400 mg every 12 hours:
- CrCl 20-50 mL/min: 400 mg every 24 hours
- CrCl <20 mL/min: 200 mg every 24 hours
Hepatic Dose Adjustments
In patients with severe liver dysfunction (cirrhosis with or without ascites), do not exceed 400 mg per day total 1.
Important Administration Considerations
Drug Interactions Affecting Absorption
Separate ofloxacin from antacids, sucralfate, iron, multivitamins with zinc, or didanosine by at least 2 hours before or after ofloxacin administration 1. These divalent and trivalent cations markedly decrease fluoroquinolone absorption 4.
Alternative Routes
All oral formulations can be administered via nasogastric or gastric tubes 2.
Common Pitfalls
Underdosing in children: Recent pharmacokinetic data suggests that current weight-based dosing may result in subtherapeutic exposures, particularly in children <24 kg 5. However, higher doses require further safety validation.
Forgetting renal adjustment: Unlike some antibiotics that only require adjustment at very low GFR, ofloxacin needs dose modification starting at CrCl <50 mL/min.
Using in myasthenia gravis: Ofloxacin has neuromuscular blocking activity and is contraindicated in patients with myasthenia gravis due to risk of respiratory failure 1.
Inappropriate pediatric use: Reserve for multidrug-resistant infections or bioterrorism scenarios only, not routine infections where safer alternatives exist.
Ignoring drug interactions: Failure to separate administration from cation-containing products can result in treatment failure due to poor absorption.